Jian Jin

Jian Jin

Chemical Biology and Drug Discovery, Icahn School of Medicine at Mount Sinai

Affiliated withIcahn School of Medicine at Mount SinaiIcahn School of Medicine at Mount Sinai

Research Area

Biography

Jian Jin has not added Biography.
If you are Jian Jin and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Publication title

Cited by 7

2018

Other Publications

Article
Year
Development of a S-adenosylmethionine analog that intrudes the RNA-cap binding site of Zika methyltransferase.

Scientific reports| PubMed ID: 28487506

2017
2015
Selective inhibitors of protein methyltransferases.

Journal of medicinal chemistry| PubMed ID: 25406853

2015
Chemical probes of histone lysine methyltransferases.

ACS chemical biology| PubMed ID: 25423077

2015
2014
2014
2014
2015
2015
Targeting EZH2 and PRC2 dependence as novel anticancer therapy.

Experimental hematology| PubMed ID: 26027790

2015
2015
Effects of β-Arrestin-Biased Dopamine D2 Receptor Ligands on Schizophrenia-Like Behavior in Hypoglutamatergic Mice.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology| PubMed ID: 26129680

2016
The promise and peril of chemical probes.

Nature chemical biology| PubMed ID: 26196764

2015
2015
2016
2016
2016
Novel Therapeutics Targeting Epigenetics: New Molecules, New Methods.

ACS medicinal chemistry letters| PubMed ID: 26985299

2016
2016
2016
2016
2016
2016
Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists.

Journal of medicinal chemistry| PubMed ID: 27805392

2016
Distinct cortical and striatal actions of a β-arrestin-biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 27911814

2016
2017
2017
2017
2017
2017
2017
2017
2018
Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 28490465

2017
Recent progress in developing selective inhibitors of protein methyltransferases.

Current opinion in chemical biology| PubMed ID: 28662389

2017
Structure-activity relationship studies of G9a-like protein (GLP) inhibitors.

Bioorganic & medicinal chemistry| PubMed ID: 28662962

2017
Report and Application of a Tool Compound Data Set.

Journal of chemical information and modeling| PubMed ID: 29035535

2017
2018
2018
2018
2018
2017
2018
2018
Proteolysis Targeting Chimeras (PROTACs) of Anaplastic Lymphoma Kinase (ALK).

European journal of medicinal chemistry| PubMed ID: 29627725

2018
Structural determinants of 5-HT receptor activation and biased agonism.

Nature structural & molecular biology| PubMed ID: 30127358

2018
Influenza virus infection causes global RNAPII termination defects.

Nature structural & molecular biology| PubMed ID: 30177761

2018